HUP0000141A2 - Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására - Google Patents

Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására

Info

Publication number
HUP0000141A2
HUP0000141A2 HU0000141A HUP0000141A HUP0000141A2 HU P0000141 A2 HUP0000141 A2 HU P0000141A2 HU 0000141 A HU0000141 A HU 0000141A HU P0000141 A HUP0000141 A HU P0000141A HU P0000141 A2 HUP0000141 A2 HU P0000141A2
Authority
HU
Hungary
Prior art keywords
pellets containing
medicative
agent
producing
weight
Prior art date
Application number
HU0000141A
Other languages
English (en)
Inventor
Johannes Heinrich Bartholomäus
Iris Ziegler
Original Assignee
GRÜNENTAL GmbH.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GRÜNENTAL GmbH. filed Critical GRÜNENTAL GmbH.
Publication of HU0000141D0 publication Critical patent/HU0000141D0/hu
Publication of HUP0000141A2 publication Critical patent/HUP0000141A2/hu
Publication of HUP0000141A3 publication Critical patent/HUP0000141A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya eljárás valamely <> 0,5 g/ml vízoldhatóságúgyógyászati hatóanyagból 50 tömeg% mennyiséget tartalmazó pelletekelőállítására a hatóanyagtartalmú keverék vízzel történő granulálása,extrudálás, gömbölyítés és a nedves pelletek szárítása útján olymódon, hogy a víztartalmú keverék az alábbi komponensekből áll: A)legalább 50 tömeg% mennyiségben legalább egy, <> 0,5 g/ml,vízoldhatóságú hatóanyag; és B) legfeljebb 50 tömeg% mennyiségben a)15-25 mm közepes részecskenagyságú mikrokristályos cellulóz, és b) 10-25 mm közepes részecskenagyságú alacsony helyettesítési fokú hidroxi-propil-cellulóz kombinációja; mimellett az a) és b) komponenst 4 : 6 - 6 : 4 tömegaránybanalkalmazzák. Ó
HU0000141A 1999-01-18 2000-01-17 Process for producing the pellets containing at most 90 mass per cent medicative agent HUP0000141A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19901692A DE19901692C2 (de) 1999-01-18 1999-01-18 Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes

Publications (3)

Publication Number Publication Date
HU0000141D0 HU0000141D0 (en) 2000-03-28
HUP0000141A2 true HUP0000141A2 (hu) 2000-12-28
HUP0000141A3 HUP0000141A3 (en) 2001-01-29

Family

ID=7894569

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000141A HUP0000141A3 (en) 1999-01-18 2000-01-17 Process for producing the pellets containing at most 90 mass per cent medicative agent

Country Status (18)

Country Link
US (1) US6558704B1 (hu)
EP (1) EP1020181A1 (hu)
JP (1) JP2000212068A (hu)
KR (1) KR20000076475A (hu)
CN (1) CN1161108C (hu)
AU (1) AU764280C (hu)
CA (1) CA2295470A1 (hu)
CO (1) CO4910118A1 (hu)
CZ (1) CZ291936B6 (hu)
DE (1) DE19901692C2 (hu)
HU (1) HUP0000141A3 (hu)
IL (1) IL134079A (hu)
NZ (1) NZ502264A (hu)
PE (1) PE20001414A1 (hu)
PL (1) PL337864A1 (hu)
RU (1) RU2221553C2 (hu)
SK (1) SK285423B6 (hu)
ZA (1) ZA200000169B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0203623A2 (hu) * 1999-08-31 2003-02-28 Grünenthal GmbH Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
FR2827771B1 (fr) * 2001-07-25 2003-10-24 Apis Spheromont Formulation et procede de preparation de spheroides pouvant etre fortement titres et a dispersion rapide
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
EP1519704A2 (en) * 2002-06-27 2005-04-06 Cilag AG Spherical pellet containing a water-soluble active ingredient
TW200404004A (en) * 2002-09-09 2004-03-16 Ss Pharmaceutical Co Molded medicament for promotion of sleeping
KR100510270B1 (ko) * 2002-11-29 2005-08-26 센츄론(주) 펠렛타이저를 이용한 서방성 제제의 제조방법
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en) † 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
WO2007008752A2 (en) * 2005-07-07 2007-01-18 Farnam Companies, Inc. Sustained release pharmaceutical compositions for highly water soluble drugs
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
CA2648278C (en) * 2006-04-03 2019-05-28 Isa Odidi Drug delivery composition
JP5457830B2 (ja) 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US7979151B2 (en) * 2007-12-06 2011-07-12 International Business Machines Corporation Run-time dispatch system for enhanced product characterization capability
TWI400089B (zh) * 2009-11-24 2013-07-01 Nippon Soda Co 羥烷基纖維素微粒子
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
US10966928B2 (en) 2016-03-25 2021-04-06 Universiteit Gent Oral dosage form
WO2017162852A1 (en) 2016-03-25 2017-09-28 Universiteit Gent Oral dosage form
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2018087109A1 (de) 2016-11-08 2018-05-17 Grünenthal GmbH Multipartikuläre arzneiform mit kontrollierter freisetzung von metamizol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung

Also Published As

Publication number Publication date
SK682000A3 (en) 2000-08-14
IL134079A (en) 2004-12-15
AU1244200A (en) 2000-07-20
ZA200000169B (en) 2000-08-07
CZ2000167A3 (cs) 2000-09-13
IL134079A0 (en) 2001-04-30
CA2295470A1 (en) 2000-07-18
KR20000076475A (ko) 2000-12-26
SK285423B6 (sk) 2007-01-04
HU0000141D0 (en) 2000-03-28
CN1270025A (zh) 2000-10-18
US6558704B1 (en) 2003-05-06
PL337864A1 (en) 2000-07-31
EP1020181A1 (de) 2000-07-19
RU2221553C2 (ru) 2004-01-20
AU764280B2 (en) 2003-08-14
DE19901692C2 (de) 2002-06-20
DE19901692A1 (de) 2000-07-20
AU764280C (en) 2004-06-24
CN1161108C (zh) 2004-08-11
PE20001414A1 (es) 2000-12-23
NZ502264A (en) 2001-11-30
CZ291936B6 (cs) 2003-06-18
JP2000212068A (ja) 2000-08-02
CO4910118A1 (es) 2000-04-24
HUP0000141A3 (en) 2001-01-29

Similar Documents

Publication Publication Date Title
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
CA2360647A1 (en) Fast dispersing dosage forms free of gelatin
CA2470601A1 (en) Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
HUP9901710A2 (hu) Új stabil gyógyszerkompozíciók hajtógáztól mentes aeroszolok képzésére
ATE287704T1 (de) Orodispersible tablette mit hoher homogenität und herstellungsverfahren dafür
ATE150310T1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
ATE216576T1 (de) Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
HUP0104394A2 (hu) Granulált kristályos ibuprofént tartalmazó, bevont szemcsék
HUP0204202A2 (hu) Ibuprofent tartalmazó hatóanyag-preparátum, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
TW200518785A (en) Pharmaceutical formulation
DE60233552D1 (de) Fenofibrattabletten
HUP0303178A2 (hu) Eljárások és készítmények gyógyászatilag aktív anyagok ízének csökkentésére
CA2388325A1 (en) Ciclesonide-containing aqueous pharmaceutical composition
WO2004002398A3 (en) Spherical pellet containing a water-soluble active ingredient
ATE271378T1 (de) Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen
HUP0003566A2 (hu) Eljárás dózisforma előállítására, az előállított termék és alkalmazása
JPS5455054A (en) Water-despersible compound
JPS565412A (en) Pharmaceutical composition
AU621677B2 (en) Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
AR023355A1 (es) Procedimiento de preparacion de globulos con un contenido &gt;/= 50% en peso de sustancia activa farmaceutica
NZ532449A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and Crohn&#39;s disease
EA200100794A1 (ru) Фармацевтическая композиция, ее применение и способ получения
MY105595A (en) Stable aqueous solutions of primycin pharmaceutical and cosmetic compositions containing these solutions and process for preparing same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees